Research Progress in Clinical Diagnostics and Interventions for Frailty

来源 :肿瘤营养学杂志(英文) | 被引量 : 0次 | 上传用户:Vilmar
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
A cluster of symptoms,including falls,disability,cognitive impairment,decreased autonomic activity,unintentional weight loss and fatigue,are common in older people.This “core symptom complex” defines frailty.Frailty is often related to malnutrition,but is distinguished with the presence of sarcopenia.Frailty embodies a decline in a patient\'s overall function,which is not entirely explained by a loss of skeletal muscle mass or decreases in muscle function.Frailty occurs when the individual\'s physiological reserve decreases in conjunction with internal dynamic balance disorders and physiological debility.Frailty is associated with adverse clinical outcomes including an increased risk of complications of other conditions and surgery,unintentional injury (falls and fractures),disability,a poor quality of life,and even death.Frailty is common not only in the elderly,but also in patients with cancer,cardiovascular diseases,respiratory diseases,and malnutrition.The prevalence of frailty has been reported to be between 4.0%-59.1%in different reports,and increases with age.Frailty can be diagnosed by the presence of the core symptom complex (frailty phenotype) or based on the frailty index.Early assessment and treatment can significantly improve the health prognosis of patients.Treatments aimed at maintaining an individual\'s homeostasis can be more beneficial for preventing or resolving frailty than specifically treating any underlying disease(s).Improving the patient\'s nutritional status,implementing physical exercise,and developing individualized multidisciplinary interventions may be the best ways to prevent adverse clinical outcomes in patients with frailty.This article reviews the definitions,diagnosis,epidemiology,etiology and pathogenesis of frailty,as well as the interventions that can be used to combat frailty.
其他文献
目的 探讨程序性死亡受体-1(PD-1)、程序性死亡配体-1/2(PD-L1/2)在初诊多发性骨髓瘤(NDMM)患者骨髓T细胞亚群和骨髓瘤细胞中的表达水平及其与临床特征的关系.方法 收集22例NDMM患者及18例健康对照组骨髓及临床资料,利用流式细胞术分选CD4+、CD8+T细胞及骨髓瘤细胞,观察PD-1、PD-L1/2的表达水平.结果 NDMM组CD8+T细胞水平较对照组明显升高,CD4+/CD8+比值较对照组明显降低(均P<0.05);NDMM组CD4+T细胞PD-1和PD-L2表达水平较对照组明显升
目的 比较仑伐替尼联合局部疗法与局部疗法治疗PD-L1基因阳性门脉癌栓程氏分型Ⅰ~Ⅲ型肝癌患者的临床疗效.方法 仑伐替尼联合局部疗法组患者口服仑伐替尼12 mg每天一次(体重≥60 kg)或8 mg每天一次(体重<60 kg).局部治疗组患者仅行局部治疗.回顾性分析两组患者临床资料和预后.结果 联合组和局部治疗组CR+PR分别为78.1%和53.6%.联合组有效率和疾病控制率均高于局部疗法组(P<0.05);生存分析结果提示:联合组患者的总生存率高于局部疗法组,差异有统计学意义(P<0.05).结论 仑伐
目的 探索溶质运载蛋白16A家族(SLC16A)和肺腺癌、鳞癌的临床特征及生物学行为关系.方法 通过Wilcoxon符号秩和检验分析TCGA数据库中SLC16A家族14名成员在肺腺癌、鳞癌和正常组织中的表达,采用Cox回归法评估该家族与肺腺癌、鳞癌患者总生存期和无进展生存期之间的关系;Logistic回归法评估该家族与肺腺癌、鳞癌患者TNM及临床分期的关系;通过主成分分析分别构建肺腺癌、鳞癌的SLC16A家族评分系统(Score-SLC16As);通过ROC、Log rank分析及单、多因素Cox回归法分
NKILA(NF-kappaB interacting lncRNA)是一种新近发现的长链非编码RNA,其在诸多恶性肿瘤中呈现异常表达.现有研究已证实NKILA主要通过NF-κB信号通路参与调控肿瘤的发生和发展,对肿瘤的诊断、治疗和患者预后的评估都有重要意义.本文将对NKILA在多种肿瘤中的异常表达情况和生物学功能作一综述,并对不同肿瘤中NKILA调控恶性生物学行为的上下游机制进行总结与归纳.
声动力疗法(SDT)是一种利用声敏剂和低强度超声(US)结合治疗恶性肿瘤的新型无创治疗方法,SDT由光动力疗法(PDT)发展而来.由于超声波相对于光在组织中的传输深度更深,且声敏剂经过诱导而具有靶向性,同时还能利用超声波对声敏剂进行实时监测,所以SDT在肿瘤部位定位和激活深部组织内的敏化剂方面有着显著的优势.因此,与PDT相比,SDT可用于治疗范围更广、深度更深、不易接近的肿瘤.热疗(HT)作为一种辅助疗法应用于各种既定的癌症治疗,其机制是将载瘤组织的温度提高到40℃~43℃,使其发生不可逆的损伤.本文就
化疗药物是治疗中晚期肿瘤的有效方法.近年的研究表明,化疗药物还具有免疫调节作用.部分化疗药物可以通过诱导肿瘤细胞免疫原性细胞死亡或者进行“免疫原性调节”增强抗肿瘤免疫.化疗药物还可以影响免疫细胞和肠道菌群.同时,多项化疗联合免疫检查点抑制剂(ICIs)的临床试验正在开展.本文深入探讨化疗药物的免疫调节作用以及化疗与ICIs联合治疗癌症的潜力,希望能为化疗药物的临床应用提供借鉴.
Background The serum albumin (Alb) level often decreases early in the postoperative period.However,it is unclear whether a decline in the serum albumin level (△Alb) is a predictor of postoperative complications.We aimed to determine the relationship betwe
Colorectal cancer is the third most common cancer worldwide.Etiology of colon cancer continues to be investigated with research findings ranging from environment to diet to inherited gene mutations.Risk factors associated with colon cancer include familia
Background Chronic renal failure-induced sarcopenia (CRF-S) seriously affects public health by increasing morbidity and mortality.This study evaluated the therapeutic effects of β-hydroxy-β-methylbutyrate acid(HMB) and the underlying mechanism in an adeni
Background Patients with advanced cancer often present with malnutrition.Globally,minority populations frequently suffer from higher rates of malnutrition than the majority group.It was unknown whether the nutritional status of cancer patients is differen